Related Experiment Video
Updated: Mar 8, 2026

Author Spotlight: Point-of-Care Ultrasound for Gastric Content Assessment and Risk Stratification in Perioperative Care
Published on: September 22, 2023
Proton pump inhibitors: Risks of long-term use
Leonardo Henry Eusebi1,2, Stefano Rabitti1, Maria Laura Artesiani1
1Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Gastroenterology and Endoscopy Unit, Sant'Orsola University Hospital, Bologna, Italy.
Proton pump inhibitors (PPIs) are widely used but may cause harm. This review examines the latest evidence on long-term PPI side effects like kidney damage and dementia.
Area of Science:
- Pharmacology
- Gastroenterology
- Nephrology
Background:
- Proton pump inhibitors (PPIs) are frequently prescribed, with increasing long-term use.
- Concerns exist regarding PPI overprescription and use for inappropriate conditions.
- Potential adverse effects of long-term PPI use warrant thorough investigation.
Purpose of the Study:
- To review recent literature on adverse effects associated with long-term proton pump inhibitor treatment.
- To discuss potential biological mechanisms underlying these adverse effects.
Main Methods:
- Systematic review of recent scientific literature.
- Analysis of studies investigating PPIs' long-term side effects.
- Discussion of proposed biological mechanisms for adverse events.
Main Results:
- Evidence links long-term PPI use to various adverse effects, including drug interactions, infections, nutrient malabsorption, kidney damage, and dementia.
- While biological mechanisms are often plausible, clinical evidence for some adverse effects remains weak.
- Recent research highlights kidney damage and cognitive decline as significant concerns.
Conclusions:
- Long-term proton pump inhibitor therapy is associated with a growing list of potential adverse effects.
- Further research is needed to strengthen the clinical evidence and elucidate mechanisms of PPI-related complications.
- Careful consideration of PPI risks versus benefits is crucial for long-term patient management.
Related Concept Videos
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Drug toxicity: Drug–Drug Interaction
